425 related articles for article (PubMed ID: 27634019)
1. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.
Morton LM; Saber W; Baker KS; Barrett AJ; Bhatia S; Engels EA; Gadalla SM; Kleiner DE; Pavletic S; Burns LJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):367-378. PubMed ID: 27634019
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.
Bevans M; El-Jawahri A; Tierney DK; Wiener L; Wood WA; Hoodin F; Kent EE; Jacobsen PB; Lee SJ; Hsieh MM; Denzen EM; Syrjala KL
Biol Blood Marrow Transplant; 2017 Apr; 23(4):538-551. PubMed ID: 27660168
[TBL] [Abstract][Full Text] [Related]
3. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
4. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
[TBL] [Abstract][Full Text] [Related]
5. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
6. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.
Battiwalla M; Hashmi S; Majhail N; Pavletic S; Savani BN; Shelburne N
Biol Blood Marrow Transplant; 2017 Jan; 23(1):6-9. PubMed ID: 27989931
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.
Gea-Banacloche J; Komanduri KV; Carpenter P; Paczesny S; Sarantopoulos S; Young JA; El Kassar N; Le RQ; Schultz KR; Griffith LM; Savani BN; Wingard JR
Biol Blood Marrow Transplant; 2017 Jun; 23(6):870-881. PubMed ID: 27751936
[TBL] [Abstract][Full Text] [Related]
8. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
Bhatia S; Davies SM; Scott Baker K; Pulsipher MA; Hansen JA
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1428-35. PubMed ID: 21763253
[TBL] [Abstract][Full Text] [Related]
9. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Biol Blood Marrow Transplant; 2012 Mar; 18(3):348-71. PubMed ID: 22178693
[TBL] [Abstract][Full Text] [Related]
12. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Hematol Oncol Stem Cell Ther; 2012; 5(1):1-30. PubMed ID: 22446607
[TBL] [Abstract][Full Text] [Related]
13. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.
Shaw BE; Hahn T; Martin PJ; Mitchell SA; Petersdorf EW; Armstrong GT; Shelburne N; Storer BE; Bhatia S
Biol Blood Marrow Transplant; 2017 Jan; 23(1):10-23. PubMed ID: 27590102
[TBL] [Abstract][Full Text] [Related]
14. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.
Hashmi SK; Bredeson C; Duarte RF; Farnia S; Ferrey S; Fitzhugh C; Flowers MED; Gajewski J; Gastineau D; Greenwald M; Jagasia M; Martin P; Rizzo JD; Schmit-Pokorny K; Majhail NS
Biol Blood Marrow Transplant; 2017 May; 23(5):717-725. PubMed ID: 27713091
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers MED; Savani BN; Shaw BE; ;
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1493-1503. PubMed ID: 27184625
[TBL] [Abstract][Full Text] [Related]
17. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Bone Marrow Transplant; 2012 Mar; 47(3):337-41. PubMed ID: 22395764
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers ME; Savani BN; Shaw BE
Bone Marrow Transplant; 2017 Feb; 52(2):173-182. PubMed ID: 27548466
[TBL] [Abstract][Full Text] [Related]
19. Old and new cancers after hematopoietic-cell transplantation.
Majhail NS
Hematology Am Soc Hematol Educ Program; 2008; ():142-9. PubMed ID: 19074072
[TBL] [Abstract][Full Text] [Related]
20. [Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation].
Majhail NS; Rizzo JD; Lee SJ; Aljurf M; Atsuta Y; Bonfim C; Burns LJ; Chaudhri N; Davies S; Okamoto S; Seber A; Socie G; Szer J; Van Lint MT; Wingard JR; Tichelli A; ; ; ; ; ; ;
Rinsho Ketsueki; 2014 Jun; 55(6):607-32. PubMed ID: 24975331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
